252 related articles for article (PubMed ID: 16140547)
1. Molecular and cellular alterations in the Pitx3-deficient midbrain dopaminergic system.
Smits SM; Mathon DS; Burbach JP; Ramakers GM; Smidt MP
Mol Cell Neurosci; 2005 Nov; 30(3):352-63. PubMed ID: 16140547
[TBL] [Abstract][Full Text] [Related]
2. Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice.
Hwang DY; Ardayfio P; Kang UJ; Semina EV; Kim KS
Brain Res Mol Brain Res; 2003 Jun; 114(2):123-31. PubMed ID: 12829322
[TBL] [Abstract][Full Text] [Related]
3. Early developmental failure of substantia nigra dopamine neurons in mice lacking the homeodomain gene Pitx3.
Smidt MP; Smits SM; Bouwmeester H; Hamers FP; van der Linden AJ; Hellemons AJ; Graw J; Burbach JP
Development; 2004 Mar; 131(5):1145-55. PubMed ID: 14973278
[TBL] [Abstract][Full Text] [Related]
4. Striatal neuroadaptation and rescue of locomotor deficit by L-dopa in aphakia mice, a model of Parkinson's disease.
van den Munckhof P; Gilbert F; Chamberland M; Lévesque D; Drouin J
J Neurochem; 2006 Jan; 96(1):160-70. PubMed ID: 16269007
[TBL] [Abstract][Full Text] [Related]
5. Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons.
Cepeda C; André VM; Yamazaki I; Wu N; Kleiman-Weiner M; Levine MS
Eur J Neurosci; 2008 Feb; 27(3):671-82. PubMed ID: 18279319
[TBL] [Abstract][Full Text] [Related]
6. Specificity of Pitx3-Dependent Gene Regulatory Networks in Subsets of Midbrain Dopamine Neurons.
Bifsha P; Balsalobre A; Drouin J
Mol Neurobiol; 2017 Sep; 54(7):4921-4935. PubMed ID: 27514757
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid counteracts developmental defects in the substantia nigra caused by Pitx3 deficiency.
Jacobs FM; Smits SM; Noorlander CW; von Oerthel L; van der Linden AJ; Burbach JP; Smidt MP
Development; 2007 Jul; 134(14):2673-84. PubMed ID: 17592014
[TBL] [Abstract][Full Text] [Related]
8. The transcription factor Pitx3 is expressed selectively in midbrain dopaminergic neurons susceptible to neurodegenerative stress.
Luk KC; Rymar VV; van den Munckhof P; Nicolau S; Steriade C; Bifsha P; Drouin J; Sadikot AF
J Neurochem; 2013 Jun; 125(6):932-43. PubMed ID: 23331067
[TBL] [Abstract][Full Text] [Related]
9. The transcription factor PITX3 is associated with sporadic Parkinson's disease.
Fuchs J; Mueller JC; Lichtner P; Schulte C; Munz M; Berg D; Wüllner U; Illig T; Sharma M; Gasser T
Neurobiol Aging; 2009 May; 30(5):731-8. PubMed ID: 17905480
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of the homeobox gene Pitx3 in midbrain dopaminergic neurons.
Korotkova TM; Ponomarenko AA; Haas HL; Sergeeva OA
Eur J Neurosci; 2005 Sep; 22(6):1287-93. PubMed ID: 16190884
[TBL] [Abstract][Full Text] [Related]
11. In-vitro analysis of Pitx3 in mesodiencephalic dopaminergic neuron maturation.
Papanikolaou T; Amano T; Lennington J; Sink K; Farrar AM; Salamone J; Yang X; Conover JC
Eur J Neurosci; 2009 Jun; 29(12):2264-75. PubMed ID: 19508691
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic segregation of aphakia and Pitx3-null mutants reveals that Pitx3 deficiency increases consolidation of specific movement components.
Kas MJ; van der Linden AJ; Oppelaar H; von Oerthel L; Ramakers GM; Smidt MP
Behav Brain Res; 2008 Jan; 186(2):208-14. PubMed ID: 17919745
[TBL] [Abstract][Full Text] [Related]
13. Signalling through phospholipase C beta 4 is not essential for midbrain dopaminergic neuron survival.
Smits SM; van der Nobelen S; Hornman KJ; von Oerthel L; Burbach JP; Smidt MP
Neuroscience; 2005; 136(1):171-9. PubMed ID: 16198487
[TBL] [Abstract][Full Text] [Related]
14. Lack of Reelin causes malpositioning of nigral dopaminergic neurons: evidence from comparison of normal and Reln(rl) mutant mice.
Nishikawa S; Goto S; Yamada K; Hamasaki T; Ushio Y
J Comp Neurol; 2003 Jun; 461(2):166-73. PubMed ID: 12724835
[TBL] [Abstract][Full Text] [Related]
15. K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons.
Liss B; Haeckel O; Wildmann J; Miki T; Seino S; Roeper J
Nat Neurosci; 2005 Dec; 8(12):1742-51. PubMed ID: 16299504
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of the midbrain dopaminergic pathways during mouse development.
Hu Z; Cooper M; Crockett DP; Zhou R
J Comp Neurol; 2004 Aug; 476(3):301-11. PubMed ID: 15269972
[TBL] [Abstract][Full Text] [Related]
17. Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1: a new genetic model for Parkinson's disease?
Le Pen G; Sonnier L; Hartmann A; Bizot JC; Trovero F; Krebs MO; Prochiantz A
Parkinsonism Relat Disord; 2008; 14 Suppl 2():S107-11. PubMed ID: 18585951
[TBL] [Abstract][Full Text] [Related]
18. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression.
Maingay M; Romero-Ramos M; Carta M; Kirik D
Neurobiol Dis; 2006 Sep; 23(3):522-32. PubMed ID: 16806952
[TBL] [Abstract][Full Text] [Related]
19. FGF-2 and S100beta immunoreactivities increase in reactive astrocytes, but not in microglia, in ascending dopamine pathways following a striatal 6-OHDA-induced partial lesion of the nigrostriatal system.
Chadi G; Gomide VC
Cell Biol Int; 2004; 28(12):849-61. PubMed ID: 15566955
[TBL] [Abstract][Full Text] [Related]
20. Focused motor stereotypies do not require enhanced activation of neurons in striosomes.
Glickstein SB; Schmauss C
J Comp Neurol; 2004 Feb; 469(2):227-38. PubMed ID: 14694536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
